134 related articles for article (PubMed ID: 2436204)
21. Prostate specific antigen and prostatic acid phosphatase immunoreactivity as prognostic indicators of advanced prostatic carcinoma.
Sakai H; Yogi Y; Minami Y; Yushita Y; Kanetake H; Saito Y
J Urol; 1993 May; 149(5):1020-3. PubMed ID: 7683340
[TBL] [Abstract][Full Text] [Related]
22. Prostatic involvement in bladder cancer. Prostate mapping in 20 cystoprostatectomy specimens.
Mahadevia PS; Koss LG; Tar IJ
Cancer; 1986 Nov; 58(9):2096-102. PubMed ID: 3530431
[TBL] [Abstract][Full Text] [Related]
23. The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study.
Schron DS; Gipson T; Mendelsohn G
Cancer; 1984 Jun; 53(11):2478-80. PubMed ID: 6324985
[TBL] [Abstract][Full Text] [Related]
24. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
[TBL] [Abstract][Full Text] [Related]
25. [A case of endometrioid carcinoma of the prostate].
Fukui J; Kiyota A; Nishikawa K; Nishimoto K; Nishio S; Maekawa T; Wakasa K
Hinyokika Kiyo; 1998 May; 44(5):335-7. PubMed ID: 9656106
[TBL] [Abstract][Full Text] [Related]
26. Prostate inhibin peptide (PIP) in prostate cancer: a comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP).
Garde SV; Sheth AR; Venkatesan VM; Panchal CJ; Porter AT; Grignon DJ
Cancer Lett; 1994 Apr; 78(1-3):11-7. PubMed ID: 7514089
[TBL] [Abstract][Full Text] [Related]
27. The use of immunohistochemistry in metastatic prostatic adenocarcinoma to the breast.
Green LK; Klima M
Hum Pathol; 1991 Mar; 22(3):242-6. PubMed ID: 1706305
[TBL] [Abstract][Full Text] [Related]
28. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
Mai KT; Yazdi HM; Farmer J
Prostate; 2001 May; 47(3):172-82. PubMed ID: 11351346
[TBL] [Abstract][Full Text] [Related]
29. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
30. Histopathology of prostate carcinoma. Diagnosis and differential diagnosis.
Dhom G
Pathol Res Pract; 1985 Jan; 179(3):277-303. PubMed ID: 2580293
[TBL] [Abstract][Full Text] [Related]
31. Three predominant prostatic proteins.
Abrahamsson PA; Lilja H
Andrologia; 1990; 22 Suppl 1():122-31. PubMed ID: 1720287
[TBL] [Abstract][Full Text] [Related]
32. [Papillary adenocarcinoma of the prostate: report of 4 cases].
Miki J; Ikemoto I; Shimomura T; Kiyota H; Oisi Y; Kondo I; Madarame J; Endo K; Takahashi H
Hinyokika Kiyo; 2003 Jan; 49(1):21-4. PubMed ID: 12629776
[TBL] [Abstract][Full Text] [Related]
33. Fine needle aspiration cytology of papillary endometrioid carcinoma of the prostate. The grooved nucleus as a cytologic marker.
Masood S; Swartz DA; Meneses M; Hardy NH; Prempree T
Acta Cytol; 1991; 35(4):451-5. PubMed ID: 1718114
[TBL] [Abstract][Full Text] [Related]
34. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
Wang W; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma.
Sakai H; Shiraishi K; Minami Y; Yushita Y; Kanetake H; Saito Y
Prostate; 1991; 19(3):265-72. PubMed ID: 1946042
[TBL] [Abstract][Full Text] [Related]
36. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
Genega EM; Hutchinson B; Reuter VE; Gaudin PB
Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
[TBL] [Abstract][Full Text] [Related]
37. Does prostatic ductal adenocarcinoma exist?
Bock BJ; Bostwick DG
Am J Surg Pathol; 1999 Jul; 23(7):781-5. PubMed ID: 10403300
[TBL] [Abstract][Full Text] [Related]
38. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
Bartziota EV
Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
[TBL] [Abstract][Full Text] [Related]
39. Primary prostatic signet-ring cell carcinoma.
Skodras G; Wang J; Kragel PJ
Urology; 1993 Sep; 42(3):338-42. PubMed ID: 7691016
[TBL] [Abstract][Full Text] [Related]
40. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
